Hem › Crohns sjukdom › Utah
Kliniska studier för Crohns sjukdom i Utah
8 studier för Crohns sjukdom söker deltagare vid platser i Utah.
Städer i Utah
Officiell studietext (engelska)
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Care Access - Ogden /ID# 266428, Ogden
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06548542A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- University of Utah, Salt Lake City
RekryterarFas 3
Ålder 3 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06663332An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Velocity Clinical Research, Salt Lake City-Site Number: 8400147, West Jordan
RekryterarFas 3
Ålder 16 till 80 · Alla kön · Uppdaterad 23 sep. 2026 · NCT07184931A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Care Access Research - Ogden, Ogden
RekryterarFas 2
Ålder 18 till 85 · Alla kön · Uppdaterad 22 sep. 2026 · NCT06226883A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- University of Utah Health, Salt Lake City
RekryterarFas 4
Ålder 18 till 70 · Alla kön · Uppdaterad 9 sep. 2026 · NCT06045754Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- University of Utah Health, Salt Lake City
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 7 aug. 2026 · NCT05230173Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- University of Utah, Salt Lake City
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 27 apr. 2026 · NCT06456593A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400016, Ogden
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 27 mars 2026 · NCT06958536Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.